Journal
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
Volume 156, Issue 2, Pages 473-480Publisher
MOSBY-ELSEVIER
DOI: 10.1016/j.jtcvs.2017.10.161
Keywords
-
Funding
- Edwards LifeSciences
- Medtronic
- St. Jude Medical
- Cryolife
Ask authors/readers for more resources
Bicuspid aortic valve disease is a common congenital cardiac disorder, being present in 1% to 2% of the general population. Associated aortopathy is a common finding in patients with bicuspid aortic valve disease, with thoracic aortic dilation noted in approximately 40% of patients in referral centers. Several previous consensus statements and guidelines have addressed the management of bicuspid aortic valve-associated aortopathy, but none focused entirely on this disease process. The current document is an executive summary of The American Association for Thoracic Surgery Guidelines on Bicuspid Aortic Valve-Related Aortopathy.'' All major aspects of bicuspid aortic valve aortopathy, including natural history, phenotypic expression, histology and molecular pathomechanisms, imaging, indications for surgery, surveillance, and follow-up, and recommendations for future research are contained within these guidelines. The current executive summary serves as a condensed version of the guidelines to provide clinicians with a current and comprehensive review of bicuspid aortic valve aortopathy and to guide the daily management of these complex patients.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available